ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2275

NR1H3 (LXR alpha) Gene Polymorphisms Are Associated with Systemic Lupus Erythematosus in Koreans

Ja-Young Jeon1, Hyoun-Ah Kim1 and Chang-Hee Suh2, 1Department of Rheumatology, Ajou University School of Medicine, Suwon, South Korea, 2Department of Rheumatology, Ajou University Hospital, Suwon, South Korea

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: polymorphism and systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Title: Systemic Lupus Erythematosus - Human Etiology and Pathogenesis

Session Type: Abstract Submissions (ACR)

Background/Purpose: Liver X receptorsare established sensors of lipid and cholesterol homeostasis. The recent studies have reported that LXRs are involved in regulation of inflammation and immune responses. We attempted to identify single nucleotide polymorphisms (SNPs) of the NR1H3 and NR1H2 genes, associated with the susceptibility to SLE in Korean populations.

Methods: Blood samples were collected from Korean SLE patients (n=300) and normal healthy controls (NC, n=217). Also, replication samples were collected from Korean SLE patients (n=160) and NC (n=143). SNPs were genotyped using SNaPSHOT assay. The promoter activity was analyzed by luciferase reporter assay in Hep3B cells and COS-7 cells. To investigate the effects of the stimulation, we used a functional assay of transcriptional activity and B cell proliferation assay. To investigate whether the genetic polymorphism changed a transcription factor binding, we performed an electrophoretic mobility shift assay.

Results: We have identified five polymorphisms (-1851 T>C and -1830 T>C in the promoter region, -1003 G>A, -840 C>A and -115 G>A in the intron 1 region) including one novel SNPs (-1003 G>A) in the NR1H3 gene. Two SNPs in the NR1H3 gene, -840 C>A and -115 G>A, showed the complete linkage disequilibrium. There was significant difference in the -1830 T>C polymorphism (co: p=0.001), -1003 G>A polymorphism (co: p=0.002), -115 G>A polymorphism (co: p<0.001) between SLE and NC. These results were consistent with those of replication samples. Three common haplotypes for four polymorphisms were constructed: HT1 [TTGG], HT2 [CTGG] and HT3 [TCAA]. There was significant difference between SLE and NC in the observed haplotype HT1 [TTGG] (co: p=0.033) and HT3 [TCAA] (co: p=0.008). In the -1830 T>C polymorphism, arthritis was significantly more common in the SLE patients with the -1830 C allele (p=0.005). The -1003 G>A polymorphism was significantly associated with oral ulcer (p=0.039), arthritis (p=0.006), anti-dsDNA (p=0.041) and elevated triglyceride (p=0.007). The -115 G>A polymorphism was significantly associated with oral ulcer (p=0.024), arthritis (p=<0.001) and elevated triglyceride (p=0.011). Luciferase activity of the constructs containing -1830 Cand -1003 A was lower than that of the constructs containing -1830 T and -1003 G (p=0.009 and p=0.030, respectively). Moreover, promoter activity of the -1830 C and -1003 A was less enhanced when compared to that of the -1830 T and -1003 G in GW3965 and T0901317 treated cells (p=0.034 and p<0.001, respectively). Proliferation of -1830 TC type was increased when compared to that of -1830 TT type in basal, GW3965 and T0901317 treated B cells from SLE patients (p=0.011, p= 0.040 and p=0.017, respectively). We found that transcription factor GATA-binding protein 3 (GATA3) protein preferentially bound the -1830 T promoter.

Conclusion: These results suggest that the NR1H3 gene genetic polymorphisms may be associated with disease susceptibility and clinical manifestations of SLE in Korean population. Specially, -1830 T>C polymorphism within NR1H3 promoter region may be involved in regulation of NR1H3 expression.


Disclosure:

J. Y. Jeon,
None;

H. A. Kim,
None;

C. H. Suh,
None.

  • Tweet
  • Email
  • Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/nr1h3-lxr-alpha-gene-polymorphisms-are-associated-with-systemic-lupus-erythematosus-in-koreans/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology